Argent Trust Co’s Axcelis ACLS Stock Holding History

Argent Trust Co’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,500	Closed	-$245K	–	648
2023 Q3	$245K	Sell	1,500 -210	-12%	-$36.9K	0.01%	530
2023 Q2	$313K	Buy	+1,710	New	+$246K	0.02%	478

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Argent Trust Co's ACLS Position: Q4 2023 in Review

Argent Trust Co sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 1,500 shares — an estimated $245K sold.

Argent Trust Co first reported a position in ACLS in Q2 2023 and held it in 2 quarters. The position peaked at $313K in Q2 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

Argent Trust Co reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
Argent Trust Co sold 1,500 Axcelis shares in Q4 2023, an estimated $245K.
Argent Trust Co first reported a position in Axcelis in Q2 2023 and held it in 2 quarters.
Argent Trust Co's Axcelis position peaked at $313K in Q2 2023.
421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Argent Trust Co's 13F filing for Q4 2023, filed 9 Feb 2024.